| Target Species |
Dogs |
| Active Substances |
Milbemycin Oxime (A3 and A4), Praziquantel |
| Pharmaceutical Form |
Chewable tablet |
| Therapeutic Group |
Anthelmintic |
| Authorisation Route |
National (Informed Consent) |
| Legal Category |
POM-V |
| Controlled Drug Status |
Not a controlled drug |
| Marketing Authorisation Holder |
Elanco Europe Ltd. |
| Distributors |
<span>Elanco Europe Limited</span> |
| Territory |
Great Britain |
| SPC |
Elanco Milbemycin – Praziquantel 12.5 mg/125 mg Chewable Tablets for Dogs SPC |
| UKPAR |
Elanco Milbemycin – Praziquantel 12.5 mg/125 mg Chewable Tablets for Dogs UKPAR |
